ArticleOncoTargets and therapy2026

miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.